Antibiotic treatment in mice infected with Japanese Borrelia garinii: Efficacy of ceftriaxone for eradicating the infection induced by Ixodes persulcatus tick bites

Microbiology and Immunology

Volumn 41, Issue 2, 1997, Pages 165-168

  Konishi, Tatsuya ^a   Nakao, Minoru ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Antibiotics; Borrelia garinii; Ceftriaxone; Clarithromycin; Erythromycin; Japan

Indexed keywords

CEFTRIAXONE; CLARITHROMYCIN; ERYTHROMYCIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BORRELIA; BORRELIA GARINII; DOSE RESPONSE; DRUG EFFICACY; FEMALE; INFECTION CONTROL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RECURRENCE RISK; TICK BITE; TISSUE DISTRIBUTION;

EID: 0031042879     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1997.tb01182.x     Document Type: Article

References (24)

1. Alder, J., Mitten, M., Jarvis, K., Gupta, P., and Clement, J. 1993. Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo. Antimicrob. Agents Chemother. 37: 1329-1333.
2. Barbour, A.G. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57: 521-525.
3. Center for Disease Control. 1993. Ceftriaxone-associated biliary complications of treatment of suspected disseminated Lyme disease - New Jersey, 1990-1992. MMWR Morb. Mortal. Wkly. Rep. 42: 39-42.
4. Dattwyler, R.J., Halperin, J.J., Volkman, D.J., and Luft, B.J. 1988. Treatment of late Lyme borreliosis - randomized comparison of ceftriaxone and penicillin. Lancet 1 (8596): 1191-1194.
5. Fujita, H., Yamada, K., Kurita, T., Masuzawa, T., and Yanagihara Y. 1995. In vitro and in vivo antibiotic susceptibility of Lyme disease Borrelia isolated from the ixodid tick in Japan. J. Dermatol. 22: 935-938.
6. Fukunaga, M., and Koreki, Y. 1996. A phylogenetic analysis of Borrelia burgdorferi sensu lato isolates associated with Lyme disease in Japan by flagellin gene sequence determination. Int. J. Syst. Bacteriol. 46: 416-421.
7. Fukunaga, M., and Hamase, A. 1995. Outer surface protein C gene sequence analysis of Borrelia burgdorferi sensu lato isolates from Japan. J. Clin. Microbiol. 33: 2415-2420.
8. Fukunaga, M., Hamase, A., Okada, K., and Nakao, M. 1996. Borrelia tanukii sp. nov. and Borrelia turdae sp. nov. found from ixodid ticks in Japan: rapid species identification by 16S rRNA gene-targeted PCR analysis. Microbiol. Immunol. 40: in press.
9. Fukunaga, M., Takahashi, Y., Tsuruta, Y., Matsushita, O., Ralph, D., McClelland, M., and Nakao, M. 1995. Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. Int. J. Syst. Bacteriol. 45: 804-810.
10. Hashimoto, Y., Kawagishi, N., Sakai, H., Takahashi, H., Matsuo, S., Nakao, M., Miyamoto, K., and Iizuka, H. 1995. Lyme disease in Japan: analysis of Borrelia species using rRNA gene restriction fragment length polymorphism. Dermatology 191: 193-198.
11. Johnson, R.C., Kodner, C., and Russell, M. 1987. In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob. Agents Chemother. 31: 164-167.
12. Kawabata, H., Masuzawa, T., and Yanagihara, Y. 1993. Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan. Microbiol. Immunol. 37: 843-848.
13. Klempner, M.S., Noring, R., and Rogers, R.A. 1993. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J. Infect. Dis. 167: 1074-1081.
14. Masuzawa, T., Yamada, K., Kawabata, H., and Yanagihara, Y. 1994. In vitro antibiotic susceptibilities of Borrelia isolates from erythema migrans lesion of Lyme disease patients in Japan. Microbiol. Immunol. 38: 399-402.
15. Moody, K.D., Adams, R.L., and Barthold, S.W. 1994. Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice. Antimicrob. Agents Chemother. 38: 1567-1572.
16. Nakao, M., and Miyamoto, K. 1994. Susceptibility ot Ixodes persulcatus and I. ovatus (Acari: Ixodidae) to Lyme disease spirochetes isolated from humans in Japan. J. Med. Entomol. 31: 467-473.
17. Nakao, M., Miyamoto, K., and Fukunaga, M. 1994. Lyme disease spirochetes in Japan: enzootic transmission cycles in birds, rodents, and Ixodes persulcatus ticks. J. Infect. Dis. 170: 878-882.
18. Nakao, M., and Sato, Y. 1996. Refeeding activity of immature ticks of Ixodes persulcatus and transmission of Lyme disease spirochete by partially fed larvae. J. Parasitol. 82: 669-672.
19. Nakao, M., Uchikawa, K., and Dewa, H. 1996. Distribution of Borrelia species associated with Lyme disease in the subalpine forests of Nagano prefecture, Japan. Microbiol. Immunol. 40: 307-311.
20. Preac-Mursic, V., Wilske, B., Schierz, G., Holmburger, M., and Süß E. 1987. In vitro and in vivo susceptibility of Borrelia burgdorferi. Eur. J. Clin. Microbiol. 6: 424-426.
21. Preac-Mursic, V., Wilske, B., Schierz, G., and Süß E. 1989. Comparative antimicrobial activities of new macrolides against Borrelia burgdorferi. Eur. J. Clin. Microbiol. Infect. Dis. 8: 651-653.
22. Steere A.C., Malawista, S.E., Newman, J.H., Spieler, P.N., and Bartenhagen, N.H. 1980. Antibiotic therapy in Lyme disease. Ann. Intern. Med. 93: 1-8.
23. Strickland, G.T., Caisley, I., Woubeshet, M., and Israel, E. 1994. Antibiotic therapy for Lyme disease in Maryland. Public Health Rep. 109: 745-749.
24. van Dam, A.P., Kuiper, H., Vos, K., Widjojokusumo, A., de Jongh, B.M., Spanjaard, L., Ramselaar, A.C., Kramer, M.D., and Dankert, J. 1993. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin. Infect. Dis. 17: 708-717.